Glucosamine therapy for knee osteoarthritis: pharmacokinetic considerations

References

• Altman RD, Asch E, Bloch D et al. Development of criteria for the classification and reporting of osteoarthritis: classification of osteoarthritis of the knee. Arthritis Rheum.29(8), 1039–1049 (1986).
   PubMed Web of Science ®Google Scholar
• Fox BA, Stephens MM. Glucosamine hydrochloride for the treatment of osteoarthritis symptoms. Clin. Interv. Aging2(4), 599–604 (2007).
   PubMed Web of Science ®Google Scholar
• Felson DT. Osteoarthritis of the knee. N. Engl. J. Med.354(8), 841–848 (2006).
   PubMedGoogle Scholar
• Woolf AD, Pfleger B. Burden of major musculoskeletal conditions. Bull. World Health Organ.81(9), 646–656 (2003).
   PubMed Web of Science ®Google Scholar
• Dawson J, Linsell L, Doll H et al. Assessment of the Lequesne index of severity for osteoarthritis of the hip in an elderly population. Osteoarthritis Cartilage13(10), 854–860 (2005).
   PubMed Web of Science ®Google Scholar
• Mapel DW, Shainline M, Paes K, Gunter M. Hospital, pharmacy and outpatient costs for osteoarthritis and chronic back pain. J. Rheumatol.31(3), 573–583 (2004).
   PubMed Web of Science ®Google Scholar
• Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC. Pain exacerbation as a major source of lost productive time in US workers with arthritis. Arthritis Rheum.53(5), 673–681 (2005).
   PubMed Web of Science ®Google Scholar
• Towheed TE, Anastassiades T. Editorial. Glucosamine therapy for osteoarthritis: an update. J. Rheumatol.34(9), 1787–1790 (2007).
   PubMedGoogle Scholar
• Reginster JY, Deroisy R, Rovati LC et al. Long-term effects of glucosamine sulfate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet357(9252), 251–256 (2001).
   PubMed Web of Science ®Google Scholar
• Pavelka K, Gatterová J, Olejarová M, Machacek S, Giacovelli G, Rovati LC. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomised, placebo-controlled, double-blind study. Arch. Intern. Med.162(18), 2113–2123 (2002).
   PubMed Web of Science ®Google Scholar
• Herrero-Beaumont G, Ivorra JAR, Trabado MC et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms. A randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum.56(2), 555–567 (2007).
   PubMed Web of Science ®Google Scholar
• Vangsness CT, Spiker W, Erickson J. A review of evidence-based medicine for glucosamine and chondroitin sulfate use in knee osteoarthritis. Arthroscopy25(1), 86–94 (2009).
   PubMed Web of Science ®Google Scholar
• Reginster JY. Editorial. The efficacy of glucosamine sulfate in osteoarthritis: financial and nonfinancial conflict of interest. Arthritis Rheum.56(7), 2105–2110 (2007).
   PubMed Web of Science ®Google Scholar
• Setnikar I, Rovati LC. Absorption, distribution, metabolism and excretion of glucosamine sulfate. Arzneimittelforschung51(II), 699–725 (2001).
   PubMed Web of Science ®Google Scholar
• Hamerman D. The biology of osteoarthritis. N. Engl. J. Med.320(20), 1322–1330 (1989).
   PubMed Web of Science ®Google Scholar
• Rodén L. Effects of hexosamines on the synthesis of chondroitin sulphuric acid in vitro. Ark. Kemi10, 345–352 (1956).
   Google Scholar
• Clegg DO, Reda DJ, Harris CL et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N. Engl. J. Med.354(8), 795–808 (2006).
   PubMed Web of Science ®Google Scholar
• Towheed TE, Maxwell L, Anastassiades TP et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst. Rev.18(2), CD002946 (2005).
   Google Scholar
• Dodge GR, Jimenez SA. Glucosamine sulfate modulates the levels of aggrecan and matrix metalloproteinase-3-synthesized by cultured human osteoarthritis articular chondrocytes. Osteoarthritis Cartilage11(6), 424–432 (2003).
   PubMed Web of Science ®Google Scholar
• Mroz PJ, Silbert JE. Use of 3H-glucosamine and 35S-sulfate with cultured human chondrocytes to determine the effect of glucosamine concentration on formation of chondroitin sulfate. Arthritis Rheum.50(11), 3574–3579 (2004).
   PubMedGoogle Scholar
• Varghese S, Theprungsirikul P, Sahani S, Hwang N, Yarema KJ, Elisseeff JH. Glucosamine modulates chondrocyte proliferation, matrix synthesis, and gene expression. Osteoarthritis Cartilage15(1), 59–68 (2007).
   PubMed Web of Science ®Google Scholar
• Pelletier JP. Rationale for the use of structure-modifying drugs and agents in the treatment of osteoarthritis. Osteoarthritis Cartilage12(Suppl. A), S63–S68 (2004).
   Google Scholar
• Largo R, Alvarez-Soria MA, Díez-Ortego I et al. Glucosamine inhibits IL-1beta-induced NFκB activation in human osteoarthritic chondrocytes. Osteoarthritis Cartilage11(4), 290–298 (2003).
   PubMed Web of Science ®Google Scholar
• Piepoli T, Zanelli T, Letari O, Persiani S, Rovati LC, Caselli G. Glucosamine sulfate inhibits IL-1-stimulated gene expression at concentrations found in humans after oral intake. Arthritis Rheum.9(Suppl.), 1326 (2005).
   Google Scholar
• Roda A, Sabatini L, Barbieri A et al. Development and validation of a sensitive HPLC-ESI-MS/MS method for the direct determination of glucosamine in human plasma. J. Chromatogr. B844(1), 119–126 (2006).
   PubMed Web of Science ®Google Scholar
• Persiani S, Roda E, Rovati LC, Locatelli M, Giacovelli G, Roda A. Glucosamine oral bioavailability and plasma pharmacokinetics after increasing doses of crystalline glucosamine sulfate in man. Osteoarthritis Cartilage13(12), 1041–1049 (2005).
   PubMed Web of Science ®Google Scholar
• Persiani S, Rotini R, Trisolino G et al. Synovial and plasma glucosamine concentrations in osteoarthritic patients following oral crystalline glucosamine sulfate at therapeutic dose. Osteoarthritis Cartilage15(7), 764–772 (2007).
   PubMed Web of Science ®Google Scholar
• Jackson CG, Plaas AH, Barnhill JG, Harris CL, Hua C, Clegg DO. The pharmacokinetics of oral glucosamine and chondroitin sulfate in humans. Arthritis Rheum.52(9 Suppl.), L13 (2005).
   Google Scholar
• Jackson CG, Plaas AH, Barnhill JG, Harris CL, Hua C, Clegg DO. The multiple-dose pharmacokinetics of orally administered glucosamine and chondroitin sulfate in humans. Presented at: ACR/ARHP Annual Scientific Meeting. Washington, DC, USA, 10–15 November 2006.
   Google Scholar
• Persiani S, Rovati LC, Pastorini E et al. Pharmacokinetics of glucosamine in man after oral administration of crystalline glucosamine sulfate or glucosamine hydrochloride alone or in combination with chondroitin sulfate. Osteoarthritis Cartilage15(Suppl. C), C223 (2007).
   Google Scholar
• Meulyzer M, Vachon P, Beaudry F et al. Comparison of pharmacokinetics of glucosamine and synovial fluid levels following administration of glucosamine sulphate or glucosamine hydrochloride. Osteoarthritis Cartilage16(9), 973–979 (2008).
   PubMedGoogle Scholar
• Persiani S, Larger P, Canciani L, Matthews A, Hall M, Rovati LC. Evaluation of crystalline glucosamine sulfate plasma to blood partitioning and protein binding in human and mouse plasma and binding in human synovial fluid. Drug Metab. Rev.40(3), 255 (2008).
   Google Scholar
• Persiani S, Canciani L, Ricci V, Larger P, Paganini D, Rovati LC. Glucosamine does not inhibit or induce human cytochromes P450. Drug Metab. Rev.38(2), 255 (2006).
   Google Scholar
• Baron AD, Zhu JS, Zhu JH, Weldon H, Maianu L, Garvey WT. Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. J. Clin. Invest. (6), 2792–2801 (1995).
   PubMedGoogle Scholar
• Pouwels MJ, Jacobs JR, Span PN, Letterman JA, Smits P, Tack CJ. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J. Clin. Endocrinol. Metab.86(5), 2099–2103 (2001).
   PubMed Web of Science ®Google Scholar
• Muniyappa R, Karne RJ, Hall G et al. Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects. Diabetes55(11), 3142–3150 (2006).
   PubMedGoogle Scholar
• Dietary Supplement Health and Education Act of 1994, Pub. L. No. 103–417, 103rd Congress, 25 October, 1994.
   Google Scholar
• Russell AS, Aghazadeh-Habashi A, Jamali F. Active ingredient consistency of commercially available glucosamine sulfate products. J. Rheumatol.29(11), 2407–2409 (2002).
   PubMed Web of Science ®Google Scholar
• Houpt JB, McMillan R, Wein C, Paget-Dellio SD. Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee. J. Rheumatol.26(11), 2423–2430 (1999).
   PubMed Web of Science ®Google Scholar
• Rindone JP, Hiller D, Collacott E, Nordhaugen N, Arriola G. Randomized, controlled trial of glucosamine for treating osteoarthritis of the knee. West J. Med.172(2), 91–94 (2000).
   PubMedGoogle Scholar
• Hughes R, Carr A. A randomised, double-blind, placebo-controlled trial of glucosamine sulfate as an analgesic in osteoarthritis of the knee. Rheumatology41(3), 279–284 (2002).
   PubMed Web of Science ®Google Scholar
• Cibere J, Kopec JA, Thorne A et al. Randomised, double-blind, placebo-controlled glucosamine discontinuation trial in knee osteoarthritis. Arthritis Rheum.51(5), 738–745 (2004).
   PubMed Web of Science ®Google Scholar
• Rozendaal RM, Koes BW, Gerjo JVM et al. Effect of glucosamine sulfate on hip osteoarthritis: a randomized trial. Ann. Intern. Med.148, 268–277 (2008).
   PubMed Web of Science ®Google Scholar
• McAlindon T. Why are clinical trials of glucosamine no longer uniformly positive? Rheum. Dis. Clin. North Am.29(4), 789–801 (2003).
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G et al. OARSI recommendations for the management of hip and knee osteoarthritis, part I: Critical appraisal of existing treatment guidelines and systematic review of current research evidence. Osteoarthritis Cartilage15, 981–1000 (2007).
   PubMed Web of Science ®Google Scholar
• Zhang W, Moskowitz RW, Nuki G et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage16, 137–162 (2008).
   PubMed Web of Science ®Google Scholar